KDIGO Announce publication of the Nomenclature for kidney function and Disease
Key Take-Home Points 1- Use ‘kidney’ rather than ‘renal’ or ‘nephro’ when referring to kidney disease and kidney function 2- Use ‘kidney failure’ with appropriate descriptions of presence or absence of symptoms, signs, and treatment (rather than ‘end-stage’ disease since latter term is not patient-sensitive and connotes stigma) 3- Use the KDIGO definition and classification of acute kidney diseases and disorders (AKD) and acute kidney injury (AKI) (rather than alternative descriptions to define and classify severity of AKD and AKI; AKI stages (1, 2, 3) should be used to denote severity of AKI) 4- Use the KDIGO definition and classification of CKD rather than alternative descriptions to define and classify CKD (Ascertainment of CKD when GFR > 60 ml/min/1.73 m2 requires assessment for markers of kidney damage e.g., albuminuria. CKD should be classified according to cause and categories of GFR and albuminuria (CGA); severity of CKD should correspond to risk categories) 5- Use specific kidney measures such as albuminuria or decreased GFR to describe Alterations in kidney structure and function, respectively (rather than general descriptors such as ‘abnormal’ or ‘reduced’ kidney function) 6- Do not equate albuminuria or proteinuria as ‘decreased kidney function’ since they are markers of
EMAN Nephrology Club Meeting COVID 19 Experience in UAE Nephrology Community
1st Virtual meeting for EMAN 19 June 2020